Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group.
Sano H, Shimada A, Taki T, Murata C, Park MJ, Sotomatsu M, Tabuchi K, Tawa A, Kobayashi R, Horibe K, Tsuchida M, Hanada R, Tsukimoto I, Hayashi Y. Sano H, et al. Among authors: murata c. Int J Hematol. 2012 May;95(5):509-15. doi: 10.1007/s12185-012-1033-x. Epub 2012 Mar 10. Int J Hematol. 2012. PMID: 22407852
WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group.
Sano H, Shimada A, Tabuchi K, Taki T, Murata C, Park MJ, Ohki K, Sotomatsu M, Adachi S, Tawa A, Kobayashi R, Horibe K, Tsuchida M, Hanada R, Tsukimoto I, Hayashi Y. Sano H, et al. Among authors: murata c. Int J Hematol. 2013 Oct;98(4):437-45. doi: 10.1007/s12185-013-1409-6. Epub 2013 Aug 27. Int J Hematol. 2013. PMID: 23979985
Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
Tokumasu M, Murata C, Shimada A, Ohki K, Hayashi Y, Saito AM, Fujimoto J, Horibe K, Nagao M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Tomizawa D, Taga T, Tawa A, Tanaka S, Heike T, Adachi S. Tokumasu M, et al. Among authors: murata c. Leukemia. 2015 Dec;29(12):2438-41. doi: 10.1038/leu.2015.121. Epub 2015 May 15. Leukemia. 2015. PMID: 25975190 No abstract available.
Body type in mitochondrial diabetes.
Suzuki Y, Taniyama M, Atsumi Y, Hosokawa K, Asahina T, Shimada A, Murata C, Matsuoka K. Suzuki Y, et al. Among authors: murata c. Diabetologia. 1997 Aug;40(8):987-8. Diabetologia. 1997. PMID: 9267998 No abstract available.
A mitochondrial DNA variant associated with left ventricular hypertrophy in diabetes.
Momiyama Y, Furutani M, Suzuki Y, Ohmori R, Imamura S, Mokubo A, Asahina T, Murata C, Kato K, Anazawa S, Hosokawa K, Atsumi Y, Matsuoka K, Kimura M, Kasanuki H, Ohsuzu F, Matsuoka R. Momiyama Y, et al. Among authors: murata c. Biochem Biophys Res Commun. 2003 Dec 19;312(3):858-64. doi: 10.1016/j.bbrc.2003.10.195. Biochem Biophys Res Commun. 2003. PMID: 14680844 Clinical Trial.
173 results